Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Revenue: 2019-2025

Historic Revenue for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $18.7 million.

  • Burning Rock Biotech's Revenue rose 109.11% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.2 million, marking a year-over-year increase of 125.66%. This contributed to the annual value of $70.7 million for FY2024, which is 6.64% down from last year.
  • Per Burning Rock Biotech's latest filing, its Revenue stood at $18.7 million for Q3 2025, which was up 119.98% from -$93.8 million recorded in Q2 2025.
  • Over the past 5 years, Burning Rock Biotech's Revenue peaked at $154.6 million during Q3 2022, and registered a low of -$340.7 million during Q4 2023.
  • In the last 3 years, Burning Rock Biotech's Revenue had a median value of $20.8 million in 2023 and averaged $7.5 million.
  • In the last 5 years, Burning Rock Biotech's Revenue crashed by 1,529.28% in 2022 and then skyrocketed by 695.41% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Revenue (Quarterly) stood at $23.7 million in 2021, then slumped by 1,529.28% to -$339.3 million in 2022, then declined by 0.39% to -$340.7 million in 2023, then spiked by 104.44% to $15.1 million in 2024, then surged by 109.11% to $18.7 million in 2025.
  • Its last three reported values are $18.7 million in Q3 2025, -$93.8 million for Q2 2025, and $133.1 million during Q1 2025.